CDT Equity CDT
NASDAQ CDT
$0.34 -0.26 (-42.58%)
As of: Sep 10, 2026 · 1:46 PM EDT

CDT Equity (CDT) Operating Expenses (2022 - 2026)

CDT Equity's (CDT) quarterly Operating Expenses came in at $3.0 million in Q2 2026, down 39.38% on a YoY basis from $5.0 million in Q2 2025, and down 17.89% quarter-over-quarter from $3.7 million in Q1 2026.

Analysis

CDT Equity (CDT) Operating Expenses (2022 - 2026) Analysis & Trends

CDT Equity (CDT) has reported Operating Expenses for 5 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Operating Expenses fell 39.38% year-over-year to $3.0 million; the trailing twelve-month figure through Jun 2026 stood at $34.8 million (up 94.76% YoY), and the FY2025 full-year result was $36.8 million, up 138.39% from the prior year.
  • Operating Expenses fell to $3.0 million in Q2 2026 per CDT's latest filing, from $3.7 million in the prior quarter.
  • Across five years, Operating Expenses topped out at $21.2 million in Q4 2025 and bottomed at $243718.0 in Q1 2022.
  • Historically, Operating Expenses has averaged $3.7 million across 5 years, with a median of $3.0 million in 2024.
  • The sharpest annual moves came in 2023 and 2024: Operating Expenses tumbled 53.91% in 2023, then surged 1251.4% in 2024.
  • Over 5 years, Operating Expenses stood at $1.7 million in 2022, then soared by 45.1% to $2.4 million in 2023, then jumped by 44.63% to $3.5 million in 2024, then surged by 502.22% to $21.2 million in 2025, then sank by 85.81% to $3.0 million in 2026.
  • According to Business Quant data, Operating Expenses over the past three periods registered $3.0 million, $3.7 million, and $21.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 641.98 Bn 621.22 Bn 17.26 Bn 10.12 Bn
2 AbbVie 446.60 Bn 440.03 Bn 12.70 Bn 10.56 Bn
3 Merck 357.75 Bn 350.61 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 267.43 Bn 259.74 Bn 11.24 Bn -6.09 Bn
5 Pfizer 156.61 Bn 144.91 Bn 10.94 Bn 6.68 Bn
6 Sanofi 52.22 Bn 44.84 Bn 10.79 Bn -5.98 Bn
7 Revolution Medicines 42.95 Bn 42.95 Bn - 505.13 Mn
8 Incyte 24.57 Bn 20.04 Bn 1.57 Bn 976.14 Mn
9 United Therapeutics 21.31 Bn 18.65 Bn 683.80 Mn 452.50 Mn
10 CDT Equity 182,285.66 182,285.66 - 3.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.00 Mn
Mar 31, 2026 3.66 Mn
Dec 31, 2025 21.16 Mn
Sep 30, 2025 7.03 Mn
Jun 30, 2025 4.95 Mn
Mar 31, 2025 3.62 Mn
Dec 31, 2024 3.51 Mn
Sep 30, 2024 5.81 Mn
Jun 30, 2024 3.14 Mn
Mar 31, 2024 2.96 Mn
Dec 31, 2023 2.43 Mn
Sep 30, 2023 430,000.00
Jun 30, 2023 888,000.00
Mar 31, 2023 1.52 Mn
Dec 31, 2022 1.67 Mn
Sep 30, 2022 933,000.00
Jun 30, 2022 249,420.00
Mar 31, 2022 243,718.00